Want to learn more about insurance barriers that can impact patient access to treatment? Read AfPA's position statement on co-pay accumulator adjustment programs. bit.ly/2E5xbji
Co-pay accumulator adjustment programs leave patients with two options: pay up or get sick. Learn more about the access barrier leaving patients with a co-pay surprise in this infographic by CFEN. bit.ly/2IvHNcI
When prior authorization delays treatment, patients can see their symptoms worsen and their relationship with their physician erode. Learn more about the access barrier and how it harms cystic fibrosis patients: bit.ly/33pxBvr
People living with cystic fibrosis need access to patient-centered care. Find out how policymakers can help in this short video by AfPA. bit.ly/35nScQu
What began as a safeguard against unnecessary drug spending has become a significant barrier to patient access, especially for cystic fibrosis patients. Learn more: bit.ly/3p3Iryq
Sometimes insurers require health care providers to go through lengthy prior authorization processes before patients can access treatment. Learn more: bit.ly/38kb6ZZ
Prior authorization means insurance companies must approve a physician-prescribed medicine, procedure or test before a patient can get coverage. Learn more in this one-pager: bit.ly/33eYsu8
When insurers require patients "fail first" before accessing their prescribed treatment, patients can suffer. Watch this short video to learn more: bit.ly/2TkzmUJ
Patients can be denied access to their medicine for days, even weeks because of prior authorization. To learn more, read AfPA’s position statement: bit.ly/33eYsu8
CF patient Emily Schaller explains how the lifestyle she’s adopted has improved her health, and how her insurer's cost-cutting tactics needlessly delay medications, derailing her efforts. bit.ly/2SPrcS6